International pilot external quality assessment scheme for analysis and reporting of circulating tumour DNA.

Cleo KeppensElisabeth M C DequekerSimon J PattonNicola NormannoFrancesca FeniziaRachel ButlerMelanie CheethamJennifer A FairleyHannah WilliamsJacqueline A HallEd SchuuringZandra C Deansnull null

Published in: BMC cancer (2018)

The pilot scheme demonstrated the feasibility of delivering a ctDNA EQA scheme and the need for such a scheme due to high error rates in detecting low frequency clinically relevant variants. Recommendations to improve reporting of cfDNA are provided.

Keyphrases

visible light
circulating tumor
adverse drug
study protocol
randomized controlled trial
cell free
emergency department
copy number
clinical trial
gene expression
single molecule
double blind